** Shares of Tissue Repair TRP.AX rise as much as 31.8% to
A$0.290, hitting their highest level since Aug. 21, 2023
** Stock set for best day ever, if current gains hold
** Biotechnology firm says Therapeutic Goods Administration
(TGA) approval granted for co's TR Pro+ product
** Adds TGA approval for product expands marketing
indications including acute wounds and a broad range of derm
conditions
** Around 610,920 shares change hands, compared with the
30-day average volume of 29,426 shares
** Stock flat this year, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))